Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Improve Mouse Status in Septic Peritonitis


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

We examined the efficacy of embryoid bodies from 6-day induced pluripotent stem cells an in vivo sepsis model. Injection of embryoid bodies to septic mice improved the condition of their lungs and significantly increased their survival rate. Although embryoid bodies secretedsphingosine-1-phosphate in vitro, its serum levels in mouse plasma were significantly reduced compared to that in the control (untreated mice receiving PBS). Low concentrations of sphingosine-1-phosphate protected endothelial cells, while high concentrations disrupted endothelial barrier integrity. Therefore, exogenous sphingosine-1-phosphate secreted by embryoid bodies during early stage of sepsis might down regulate endogenous production of sphingosine-1-phosphate. Inhibition of excessive sphingosine-1-phosphate release protects against endothelial injury and suppresses a vicious cycle of inflammatory reactions. The obtained results open new prospects in induced pluripotent stem cells-based therapy for sepsis.

作者简介

S. Kasuda

Department of Legal Medicine, Nara Medical University

编辑信件的主要联系方式.
Email: skasuda@naramed-u.ac.jp
日本, Kashihara, Nara

R. Kudo

Department of Legal Medicine, Nara Medical University

Email: skasuda@naramed-u.ac.jp
日本, Kashihara, Nara

K. Yuui

Department of Legal Medicine, Nara Medical University

Email: skasuda@naramed-u.ac.jp
日本, Kashihara, Nara

Y. Sakurai

Department of Legal Medicine, Nara Medical University

Email: skasuda@naramed-u.ac.jp
日本, Kashihara, Nara

K. Hatake

Department of Legal Medicine, Nara Medical University

Email: skasuda@naramed-u.ac.jp
日本, Kashihara, Nara


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2019
##common.cookie##